What¿s new in antidepressant research?
Despite the availability of antidepressants for over 40 years, a
substantial proportion of depressed patients do not respond adequately
to treatment. Failure to respond effectively to treatment contributes to
physical ill-health and psychiatric morbidity, often resulting in
premature death of the depressed patient. The purpose of this volume is
to consider the possible reasons for the limitations of the currently
available antidepressants, to examine the advances in our understanding
of the psychopathology of depression and how such knowledge may assist
in the discovery of new methods of treatment. Leading international
experts in this field discuss the possible underlying reasons for
depression and limitations of current antidepressants. Opportunities for
novel therapeutic approaches to dysfunctional circadian rhythms and
mood disorders as well as current status and future perspectives for
optimizing antidepressant management of depression are reviewed.
This publication illustrates the breadth of the latest research and
is valuable reading for psychiatrists, neuroscientists and
pharmacologists.